With the NHS continuing to struggle as it responds to the current SARS-CoV-2 pandemic and the effects that COVID-19 disease is having on a heavy workload, Gillian Ewers examines the advantages that RFID and a transport and tracking system offer.
Over the past few months, SARS-CoV-2 testing has ramped up to around 250,000 per day in the UK (Pillars1&2 swabs only1). Add on the antibody testing and this represents around a 10% increase in the number of tests the UK laboratories have to handle. This rise and the need to provide the results in record time have brought historic inefficiencies back into the spotlight.
In the June issue of Pathology in Practice,2 PragmatIC outlined how innovations in radio frequency identification (RFID) technology and flexible electronics could be used to improve efficiency. In this follow-up article, the company aims to offer some hope for the future, with more specific details of an exciting trial in the north-east of England of a new sample transport and tracking system using RFID that has the potential to revolutionise pathology services and save the NHS millions of pounds.
Challenges
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.
Register
